Navigating Trends and Analysis in the Global Agrigenomics Market

According to the estimates, the highest contribution in the market size of NSCLC is from the United States followed by Japan, Germany, and the UK.One of the most exciting developments in lung cancer medicine is the introduction of targeted treatments.

The disease epidemiology included in the report provides historical as well as forecasted Non-Small Cell Lung Cancer epidemiology, which is segmented as Total Incident cases of NSCLC patients, Total Incident cases of NSCLC patients by Histology, Total Diagnosed cases of NSCLC patients by Stages, Total NSCLC cases of patients by Genetic mutation/Biomarkers, and Total Treated Cases of NSCLC patients by Line of Therapies scenario of NSCLC in the 7MM.

Click here to know more on Non-Small Cell Lung Cancer pipeline NSCLC report encloses the detailed analysis of Non-Small Cell Lung Cancer marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs.The therapies that are approved for the NSCLC treatment are Rozlytrek (Entrectinib), Imfinzi (Durvalumab), Opdivo (Nivolumab), Tecentriq (Atezolizumab), Keytruda (Pembrolizumab), Tafinlar (Dabrafenib) in combination with Mekinist (Trametinib), Tagrisso (osimertinib), Lorbrena/Lorviqua (Lorlatinib), Vizimpro (Dacomitinib), Alunbrig (Brigatinib), Alecensa (Alectinib), Vitrakvi (Larotrectinib), Portrazza (Necitumumab) along with many more.Drugs covered in the report are:-There are several key players robustly involved in developing potential products such asNazartinib (EGF816)Capmatinib (INC280)Tepmetko (tepotinib)MerestinibJNJ-61186372 (JNJ-6372)Vemurafenib Plus CobimetinibX-396 (Ensartinib)Tedopi (OSE2101)Selpercatinib (LY3527723/ LOXO-292)SAR408701Braftovi (encorafinib) + Mektovi (binimetinib)PADCEV (enfortumab vedotin/ASG-22ME)Pralsetinib (BLU-667)TAK-788: Canakinumab (ACZ885)Avelumab (Bavencio)Veliparib (ABT-888): Sitravatinib (MGCD516)TesevatinibRomiplostim: CabozantinibSym015AMG 510INCMGA00012 (MGA012)Libtayo (Cemiplimab)BavituximabM7824 (Bintrafusp alfa)And many othersKey Players covered in the report are:-Novartis PharmaceuticalsMerck KGaAEli Lilly and CompanyJanssen Research & DevelopmentHoffmann-La RocheXcoveryBeyondSpring PharmaceuticalsOSE ImmunotherapeuticsSanofiPfizerAstellas PharmaSeattle GeneticsBlueprint Medicines CorporationTakedaAbbVieKadmon CorporationAmgenSymphogenRegeneron PharmaceuticalsPeregrine PharmaceuticalsAvid BioservicesGlaxoSmithKlineAnd many othersThe report includes provides in depth analysis historical and forecasted Market Share (%) Distribution of NSCLC, Market Share (%) Distribution of NSCLC by Mutations/Biomarkers, Total Market Size of PD-L1 NSCLC, Total Market Size of BRAF NSCLC, Total Market Size of c-Met, Total Market Size of EGFR, Total Market Size of ALK as well.Market DriverMarket Barrier The reasons for buying this report:The report proffers an overview of pathophysiology, various diagnostic approaches and NSCLC treatment algorithm, including detailed chapters for marketed products and emerging therapies.Historical and forecasted Non-Small Cell Lung Cancer epidemiology in 7MM covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2017-2030.Detailed historical and forecasted NSCLC market covering the United States, EU5 and Japan from 2017-2030.Pipeline analysis across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with comprehensive clinical profiles, key cross-competition, launch date along with product development activities.Detailed Non-Small Cell Lung Cancer market size by therapies, covering the United States, EU5 and Japan from 2017-2030.Reimbursement scenario and Key Opinion Leader Views Table of ContentsKey InsightsExecutive Summary of NSCLCSWOT Analysis of NSCLCNSCLC: Market Overview at a Glance4.1.

Total Market size of NSCLC in JapanALK-Mutation—Market Size21.1.

Report MethodologyDelveInsight CapabilitiesDisclaimerAbout DelveInsight Request a Webex Demo to get a walk-through of the report:  https://www.delveinsight.com/sample-request/non-small-cell-lung-cancer-marketRelated Reports:Non-Small Cell Lung Cancer Epidemiology Forecast to 2030Non-Small Cell Lung Cancer Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020Non-Small Cell Lung Cancer Pipeline Insights, 2020About DelveInsightDelveInsight is a premier Business Consulting and Market Research firm, focused exclusively on the life science segment.

The global Agrigenomics market was valued at 3743.10 Million USD in 2017 and will reach 5463.52 Million USD by the end of 2022, growing at a CAGR of 7.86% during 2017-2022.

Agrigenomics is product and scientific services in genomics field for agriculture and livestock.

Include DNA extraction and purification, DNA/RNA sequencing, Genotyping, Gene expression profiling, Marker-assisted selection, GMO/Trait purity and other technology.

Illumina HiSeq type accounted for the highest proportion in consumption value share, with a figure of 43.99% in 2017, followed by SOLiD Sequencer type, account for 31.62% and PacBio Sequencer type account for 9.55%.

Download Free Sample Report @ https://www.radiantinsights.com/research/global-agrigenomics-market-2020-2026/request-sample The consumption value market share of global Agrigenomics in Crops use and Livestock use have been stable year by year, at 75.62% and 24.38% respectively in 2017, and for several consecutive years, the amplitude was within one percent.

Radiant Insights, Inc. data shows that North America is the biggest contributor to the Agrigenomics revenue market, accounted for 50.77% of the total global market with a revenue of 1900.33 million USD in 2017, followed by Europe, 19.55% with a revenue of 731.94 million USD.

NGS In Agrigenomics market Overview(2021-2027)This report studies the NGS In Agrigenomics Market with many aspects of the industry like the market size, market status, market trends and forecast, the report also provides brief information of the competitors and the specific growth opportunities with key market drivers.

Find the complete NGS In Agrigenomics Market analysis segmented by companies, region, type and applications in the report.The report offers valuable insight into the NGS In Agrigenomics market progress and approaches related to the NGS In Agrigenomics market with an analysis of each region.

The report goes on to talk about the dominant aspects of the market and examine each segment.Top Manufacturer’s/ Keyplayers in the Global NGS In Agrigenomics Market: Illumina, Agilent Technologies, Ontario Genomics, Genome Atlantic, LGC, BGI, Neogen, NuGen Technologies, Eurofins Genomics, and Arbor BiosciencesClick Here To Access The Sample NGS In Agrigenomics Market ReportResearch MethodologyThe various research methodologies such as the Primary research mechanism and secondary research mechanism are considered in the NGS In Agrigenomics market report.

The data that is collected in the market report is provided through these research mechanisms.

The tools such as Porter’s Five Force model is used to perform a quantitative and qualitative analysis of the NGS In Agrigenomics market.

The various historical data along with the future aspects are analyzed to provide information about the overall market size of the NGS In Agrigenomics market at various levels.Research objectives:To study and analyze the global NGS In Agrigenomics market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2027.To understand the structure of NGS In Agrigenomics market by identifying its various sub segments.Focuses on the key global NGS In Agrigenomics players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.To analyze the NGS In Agrigenomics with respect to individual growth trends, future prospects, and their contribution to the total market.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).To project the size of NGS In Agrigenomics submarkets, with respect to key regions (along with their respective key countries).To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.To strategically profile the key players and comprehensively analyze their growth strategies.The report lists the major players in the regions and their respective market share on the basis of global revenue.

Bharat Book Bureau Provides the Trending Industry Research Report on “Agrigenomics Market by Application (Crops and Livestock), Sequencer Type (Sanger Sequencing, Illumina HiSeq Family, PacBio Sequencer, SOLiD Sequencer), Objectives, and Region (North America, Europe, APAC, South America,Row) - Forecast year 2026” under Food & Beverage Market Research Reports Category.

The report offers a collection of superior Industry research, Industry analysis, competitive intelligence and Industry reports.The Global Agrigenomics Market is estimated to be USD 3.3 billion in 2021 and is projected to reach USD 5.3 billion by 2026, at a CAGR of 9.7% from 2021 to 2026.

The agrigenomics market is increasingly driven by technological advancements in systems & services of applied genomics, demonstrable increase in the efficiency and productivity of current agricultural practices, greater availability of reference genomes, and utilization of genotyping for genome-wide association studies, genomic prediction, and cultivation of gene-edited elite cultivars with desirable traits, such as high yield, stress tolerance and pest resistance along with high milk and meat yields, better health, and increased productivity in case of livestock.

The presence of next-generation sequencers has enabled researchers to quickly and effectively determine the single nucleotide polymorphisms associated with commercially important phenotypic traits and estimate the breeding value (EBV) at an earlier stage of young animals.“The Marker-assisted selection by objective is projected to grow at the highest CAGR between 2021 and 2026.”The Marker-assisted selection is expected to grow at the highest rate during the forecast period as it is cheaper and faster than any conventional phenotypic assays, depending on the trait.

Marker-assisted selection or marker-aided selection (MAS) is an indirect selection process where a trait of interest is selected based on a marker (morphological, biochemical, or DNA/RNA variation) linked to a trait of interest (e.g., productivity, disease resistance, abiotic stress tolerance, and quality), rather than on the trait itself.

Marker-assisted breeding uses DNA markers associated with desirable traits to select a plant or animal for inclusion in a breeding program early in its development.